January 19, 2025 - 22:11

Investors brace for a volatile ride as President-elect Donald Trump’s second term gets underway on Monday, bringing the promise of significant policy shifts. Market analysts are closely examining which sectors may emerge as winners and losers under the incoming administration.
Historically, Trump's policies have had a profound impact on various industries, with energy, defense, and financial sectors often benefiting from his administration's initiatives. The anticipated focus on deregulation and tax cuts is expected to give a boost to these areas, attracting investor interest. Conversely, sectors such as technology and healthcare may face headwinds due to potential regulatory changes and shifts in trade policies.
As the new term unfolds, investors are advised to stay alert and agile, ready to adapt their strategies in response to the unfolding political landscape. The uncertainty surrounding Trump's agenda, combined with the ongoing economic recovery, suggests that volatility will be a defining feature of the markets in the coming months.
May 30, 2026 - 02:29
Piper Sandler Reaffirms Overweight on Corebridge Financial (CRBG) Despite Lower Price TargetPiper Sandler has reaffirmed its Overweight rating on Corebridge Financial (CRBG) even as it lowered the price target for the stock. The firm reduced its target to $31 from $35, citing recent stock...
May 29, 2026 - 19:46
AHF Reveals Top 50 Developers and Owners in Latest IssueThe latest issue of Affordable Housing Finance has released its annual ranking of the top 50 developers and owners in the affordable housing sector. The list highlights the companies that have...
May 29, 2026 - 04:11
Americans Are Falling Behind on Their $1.25 Trillion Credit-Card BillSoaring interest rates and stubborn inflation have pushed credit card delinquencies to their highest level since the financial crisis of 2008. According to recent data, the total balance Americans...
May 28, 2026 - 17:58
OSE Immunotherapeutics to Implement a Flexible Bridge Equity FinancingFrench biotech firm OSE Immunotherapeutics has announced a flexible bridge equity financing arrangement, marking the first step in a broader global financing strategy. The company is currently...